Ciaran Scallan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Pulmonary Fibrosis

Top Venues

Expert opinion on emerging drugs

American journal of respiratory cell and molecular biology

Annals of the American Thoracic Society

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin R J Kolb
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs 29 (2) (2024)
Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin R J Kolb
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs 29 (2) (2024)
Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin R J Kolb
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs (2024)
Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin R J Kolb
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs 29 (2) (2024)
Sarah MacIsaac, Dujrath Somboonviboon, Ciaran Scallan, Martin R J Kolb
Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials. Expert opinion on emerging drugs (2024)
Toyoshi Yanagihara, Kazuya Tsubouchi, Quan Zhou, Michael Chong, Kohei Otsubo, Takuma Isshiki, Jonas Christian Schupp, Seidai Sato, Ciaran Scallan, Chandak Upagupta, Spencer Revill, Anmar Ayoub, Sy Giin Chong, Anna Dvorkin-Gheva, Naftali Kaminski, Jussi Tikkanen, Shaf Keshavjee, Guillaume Paré, Christophe Guignabert, Kjetil Ask, Martin R J Kolb
Vascular-Parenchymal Crosstalk Promotes Lung Fibrosis Through BMPR2 Signaling. American journal of respiratory and critical care medicine (2023)
Toyoshi Yanagihara, Ciaran Scallan, Kjetil Ask, Martin Rj Kolb
Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications. Expert opinion on therapeutic targets (2021)
Ciaran Scallan, Lauren Strand, Jennifer Hayes, Suha Kadura, Bridget Collins, Lawrence Ho, Carolyn Spada, Will Canestaro, Martin R J Kolb, Ganesh Raghu
R-Scale for Pulmonary Fibrosis (PF): a simple, visual tool for the assessment of health-related quality of life. The European respiratory journal (2021)
Ciaran Scallan, Aida Venado, Lisa Han, Haodong Xu, Michael Mulligan, Ganesh Raghu
Recurrent Pulmonary Fibrosis in a Lung Allograft Secondary to De Novo Antisynthetase Syndrome. Annals of the American Thoracic Society 17 (7) (2021)
Toyoshi Yanagihara, Kazuya Tsubouchi, Mahsa Gholiof, Sy Giin Chong, Kenneth E Lipson, Quan Zhou, Ciaran Scallan, Chandak Upagupta, Jussi Tikkanen, Shaf Keshavjee, Kjetil Ask, Martin R J Kolb
Connective-Tissue Growth Factor (CTGF/CCN2) Contributes to TGF-β1-Induced Lung Fibrosis. American journal of respiratory cell and molecular biology (2021)